U.S. market Closed. Opens in 16 minutes

KRBP | Kiromic BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue2.80M2.07M469.80K200.00K87.50KN/A
Gross Profit-2.80M-2.07M-469.80K-200.00K-87.50KN/A
Operating Expenses17.14M31.11M25.31M19.20M3.71M3.18M
Selling, General & Admin7.52M17.19M13.94M14.14M2.50M1.76M
Research & Development9.62M13.92M11.37M5.05M1.20M1.42M
Other Operating ExpensesN/AN/A53.40KN/AN/AN/A
Operating Income-19.94M-31.11M-25.74M-19.20M-3.71M-3.18M
Other Expenses / Income-1.01M-3.62M147.00K-3.30K-22.50K-633.10K
Before Tax Income-20.95M-34.73M-25.59M-19.20M-3.73M-3.82M
Income Tax Expenses344.70K3.45M65.60K3.30K22.50KN/A
Net Income-21.29M-38.18M-25.65M-19.20M-3.75M-3.82M
Interest Expenses-1.85M166.50K12.20K3.30K22.50K633.10K
Basic Shares Outstanding1.10M544.53K380.61K150.19K129.32K117.76K
Diluted Shares Outstanding1.10M544.53K380.61K150.19K129.32K117.76K
EBITDA-17.14M-29.44M-24.78M-19.00M-3.62M-3.10M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-22.80M-34.56M-25.58M-19.20M-3.71M-3.18M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙